Perigon Wealth Management LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 7,644 shares of the company’s stock, valued at approximately $730,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Caitlin John LLC raised its stake in Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after acquiring an additional 253 shares during the period. Avalon Trust Co purchased a new stake in Clorox in the 2nd quarter worth $29,000. Darwin Wealth Management LLC purchased a new stake in Clorox in the 2nd quarter worth $29,000. Root Financial Partners LLC raised its holdings in Clorox by 83.8% during the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after acquiring an additional 145 shares during the period. Finally, SHP Wealth Management bought a new stake in Clorox during the fourth quarter valued at about $35,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox News Summary
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Zacks Research raised its EPS forecasts for Clorox’s third-quarter 2027 and fourth-quarter 2027, and projects earnings of $6.89 per share for fiscal 2029. These increases suggest some potential for longer-term earnings growth, although they were offset by reductions elsewhere.
- Neutral Sentiment: An analysis comparing Church & Dwight (CHD) and Clorox (CLX) highlights Clorox’s higher dividend yield. However, Clorox has increased its dividend more cautiously, making the stock more attractive to current-income investors than to investors seeking rapid dividend growth. Two Consumer Staples, Two Dividend Strategies: Church & Dwight and The Clorox Company
- Negative Sentiment: A cyclospora outbreak has made consumers more cautious about buying salads, and one analyst reportedly sees declining sales for Clorox’s Hidden Valley Ranch dressing. A sustained pullback in salad consumption could weigh on brand sales and near-term revenue. Hidden Valley Ranch dressing may be a victim of this summer’s salad scare
- Negative Sentiment: Zacks Research lowered its fiscal 2027 EPS estimate to $5.82 from $6.00 and cut its fiscal 2028 forecast to $6.23 from $6.36. It also reduced estimates for the first and second quarters of fiscal 2028 and the second quarter of fiscal 2027. The firm maintains a Strong Sell rating, which is a notable negative signal despite several upward revisions.
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. During the same period in the prior year, the firm earned $2.87 EPS. The company’s revenue for the quarter was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities analysts anticipate that The Clorox Company will post 5.8 earnings per share for the current fiscal year.
Clorox Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 4.7%. This is an increase from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date is Wednesday, August 12th. Clorox’s dividend payout ratio (DPR) is 103.73%.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the company. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Barclays reissued an “underweight” rating and issued a $84.00 price target on shares of Clorox in a report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft set a $98.00 price objective on shares of Clorox in a report on Tuesday, August 4th. Evercore set a $99.00 target price on shares of Clorox in a report on Tuesday, August 4th. Finally, Wall Street Zen cut shares of Clorox from a “hold” rating to a “sell” rating in a research note on Saturday. Twelve analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $102.40.
Check Out Our Latest Stock Report on Clorox
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Stories
- Five stocks we like better than Clorox
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
